As Klotho has the potential to modulate FGF23 levels, a reduction in FGF23 could be an additional mechanism contributing the beneficial effects of recombinant Klotho in reducing CKD-induced aortic valve lesions. The gene discussed is FGF23; the disease is chronic kidney disease.